Skip to main content
. 2020 Dec 10;11:600561. doi: 10.3389/fphar.2020.600561

TABLE 1.

Potential biomarkers were selected in plasma of COX-treated rats and normal rats.

No TR (min) Compound Molecular formula m/z obsd m/z calcd Error (ppm) Ion mode Treatment group vs. control group
1 0.93 Tryptophan C11H12N2O2 227.0796 227.0796 0 + ↓**
2 0.92 Tyrosine C9H11NO3 182.0817 182.0819 1.10 + ↓*
3 0.80 Glutamine C5H10N2O3 169.0589 169.0587 –1.18 + ↓*
4 0.83 Pyroglutamine C5H8N2O2 129.0664 129.0665 0.77 + ↓*
5 11.31 Alpha-ketoglutarate C5H6O5 184.9852 184.9864 6.49 + ↓**
6 4.41 Sphingosine C18H37NO2 300.2903 300.2902 –0.33 + ↑*
7 2.80 L-Octanoylcarnitine C15H29NO4 288.2175 288.2169 –2.08 + ↓*
8 0.93 Phenylpyruvic acid C9H8O3 165.0552 165.0547 –3.03 + ↑*
9 2.45 Prolylhydroxyproline C10H16N2O4 251.1008 251.1014 2.39 + ↓*
10 5.37 LysoPC(20:4 (8Z,11Z,14Z,17Z)/0:0) C28H50NO7P 566.3223 566.3218 –0.80 + ↓**
11 6.25 LysoPC(18:1 (11Z)/0:0) C26H52NO7P 544.3379 544.3381 0.37 + ↑*
12 5.48 L-Palmitoyl carnitine C23H45NO4 400.3427 400.3432 1.25 + ↓**
13 5.66 Alpha-linolenic acid C18H30O2 279.2324 279.2314 –3.58 + ↑*
14 6.03 Tetradecanedioic acid C14H26O4 297.1468 297.15 10.77 + ↑*
15 6.28 Trimethoprim C14H18N4O3 291.1457 291.1437 –6.87 + ↑**
16 5.94 Cortolone-3-glucuronide C27H42O11 565.2625 565.2661 6.37 + ↓**
17 2.53 Creatine C4H9N3O2 130.0617 130.0623 4.61 ↓*
18 5.28 LysoPE (0:0/24:6 (6Z,9Z,12Z,15Z,18Z,21Z)) C29H48NO7P 552.3090 552.3085 –0.91 ↑*
19 7.69 Eicosapentaenoic acid C20H30O2 301.2168 301.2188 6.64 ↓*
20 5.93 12,13-Epoxy-9,15-octadecadienoic acid C18H30O3 293.2117 293.2119 0.68 ↑*
21 5.83 11,14,17-Eicosatrienoic acid C20H34O2 305.2481 305.2500 6.22 ↑**

The change trend is compared between the DOX group and the NS group. ↑ and ↓ represent up- and downregulation. *p < 0.05. **p < 0.01.